Dyslipidemia Treatment in Thailand
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Dyslipidemia?
Dyslipidemia is a condition in which one or more types of fats or lipoproteins in the blood are present at abnormal levels. These may include elevated low-density lipoprotein cholesterol (LDL-C), elevated triglycerides, low high-density lipoprotein cholesterol (HDL-C), elevated non-HDL cholesterol, or increased lipoprotein(a) [Lp(a)]. Dyslipidemia can increase the risk of atherosclerotic cardiovascular disease (ASCVD), including heart attack and stroke. Some lipid abnormalities are inherited, while others are linked to diet, obesity, diabetes, kidney disease, thyroid disorders, medications, or other medical conditions.
What is the Importance of Timely Treatment?
Timely diagnosis and management of dyslipidemia can reduce long-term exposure to atherogenic lipoproteins and lower the risk of cardiovascular complications. Dyslipidemia often causes no noticeable symptoms, so routine lipid testing and overall cardiovascular risk assessment are important. Treatment may involve lifestyle changes, statins, other lipid-lowering medicines, and management of underlying conditions.
What are the Common Symptoms of Dyslipidemia?
- Xanthelasma (Yellowish cholesterol-rich deposits around the eyelids)
- Tendon xanthomas (Firm deposits that may develop over tendons, particularly in some inherited cholesterol disorders)
- Corneal arcus (A pale ring around the cornea)
Causes and Risk Factors of Dyslipidemia
Causes
- Dyslipidemia may result from inherited genetic abnormalities, lifestyle factors, medical conditions, or medicines.
- Common contributors include diets high in saturated fats, excess body weight, physical inactivity, diabetes, hypothyroidism, chronic kidney disease, liver disease, and certain medicines.
- Familial hypercholesterolemia and other inherited lipid disorders can cause markedly elevated cholesterol levels from an early age.
Risk Factors
- Family history of high cholesterol or premature cardiovascular disease
- Unhealthy dietary patterns, particularly high intake of saturated or trans fats
- Physical inactivity
- Overweight or obesity
- Type 2 diabetes or insulin resistance
- Metabolic syndrome
- Hypothyroidism
- Chronic kidney disease
- Liver disease
- Certain hormonal or metabolic disorders
- Smoking
- Excessive alcohol intake
- Certain medicines
- Familial hypercholesterolemia or other inherited lipid disorders
- Increasing age
- Previous cardiovascular disease
Latest Research and Technologies in the Treatment of Dyslipidemia in Thailand
- Current approaches to dyslipidemia management focus on reducing atherogenic lipoproteins and assessing an individual's overall cardiovascular risk. Statins remain a first-line treatment for many patients who require medication, while non-statin therapies may be added according to cardiovascular risk, treatment response, and individual needs. Coronary artery calcium scoring may help guide treatment decisions in selected patients when the need for preventive therapy remains uncertain.
Treatment options for Dyslipidemia
Sleeve gastrectomy : A highly effective treatment for managing lipid disorders, it can lead to complete resolution or significant improvement of dyslipidemia. The surgery achieves its metabolic impact mainly through substantial weight loss and a severe reduction in calorie intake, which lowers systemic insulin resistance and reduces the liver's overproduction of triglycerides.
Cost Start From 7500Explore Options
- Clinical assessment:
- Medical and Family History: Evaluate dietary habits, physical activity, body weight, smoking, alcohol intake, medications, prior lipid results, diabetes, kidney or thyroid disease, liver disease, cardiovascular history, and family history of high cholesterol or premature ASCVD.
- Physical Examination: Assess blood pressure, body weight, waist circumference, cardiovascular findings, and physical signs of severe lipid disorders.
- Lipid Profile Assessment: A lipid panel generally evaluates total cholesterol, LDL-C, HDL-C, and triglycerides.
- Cardiovascular Risk Assessment: Assess overall ASCVD risk using clinical history and appropriate risk-prediction tools.
- Advanced Lipid Testing: Lp(a) measurement is recommended at least once in adulthood, while apoB may be useful in selected patients, particularly when triglycerides are elevated, diabetes is present, or residual cardiovascular risk needs further clarification.
- Imaging Tests:
- Coronary Artery Calcium (CAC) Scoring: Consider CT-based CAC scoring in selected adults when the need for preventive lipid-lowering treatment remains uncertain after clinical risk assessment.
- Carotid Ultrasound: Consider in selected patients when assessing vascular disease is clinically relevant, although it is not routinely required for all patients with dyslipidemia.
- Echocardiography: Consider when symptoms or findings suggest structural or functional heart disease.
- CT Coronary Angiography: Consider when clinically indicated for suspected coronary artery disease, rather than as a routine dyslipidemia test.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Dyslipidemia patients in Thailand. These Services include:
- Exercise and Physical Activity: Regular aerobic and resistance exercise can support healthy lipid levels, cardiovascular fitness, weight management, and overall cardiovascular health.
- Cardiovascular Rehabilitation: Patients with established cardiovascular disease may benefit from structured cardiac rehabilitation incorporating exercise, education, nutrition, and risk-factor management.
- Statins remain the foundation of LDL-C-lowering therapy for many patients requiring medication. If LDL-C remains above the appropriate treatment goal despite lifestyle measures and maximally tolerated statin therapy, consider additional medicines. Other therapies may be used for selected patients with severe hypertriglyceridemia or inherited lipid disorders.
Instantly Connect with our Specialists
Hospitals for Dyslipidemia in Thailand
BNH Hospital, Bangkok
Bangkok, Thailand
- Despite offering an assortment of healthcare services (including both primary and speciality care), BNH Hospital also provides a range of medical disciplines, including cardiac, liver, musculoskeletal, central nervous system (brain), gastrointestinal, children’s, and female-specific procedures. They provide patients with accurate diagnostic imaging, advanced surgical options with smaller incisions, rehabilitation services, and preventive care, utilising highly trained staff and cutting-edge technology. Through its dedicated international patient services department, BNH works with medical professionals to create individualised treatment plans for patients, based on evidence-based medicine, while providing ongoing support and assistance to ensure they have access to high-quality, patient-focused health care.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Thailand for Dyslipidemia Treatment?
- Experienced Cardiometabolic Specialists: Major Thai hospitals may offer cardiologists, endocrinologists, lipid specialists, internal medicine physicians, and other specialists who manage complex lipid disorders.
- Advanced Lipid Testing: Many centres offer comprehensive lipid profiles, Lp(a) and apoB testing, metabolic evaluation, and assessment for inherited or secondary causes of dyslipidemia when clinically indicated.
- Comprehensive Treatment Options: Patients may have access to lifestyle programmes, statins, non-statin lipid-lowering medicines, therapies for severe hypertriglyceridemia, and specialist management of familial lipid disorders.
- International Patient Support: Major Thai hospitals may provide medical-record review, specialist coordination, treatment scheduling, visa and travel assistance, accommodation support, interpretation, and follow-up services for international patients.
Frequently Asked Questions
Dyslipidemia generally does not have a fixed recovery period because it is usually a chronic metabolic condition rather than an acute illness. Cholesterol and triglyceride levels may improve within weeks to months after lifestyle changes or medication, but long-term treatment and monitoring may be needed to maintain lipid control and reduce cardiovascular risk.
Yes. Dyslipidemia itself generally does not interfere with walking. Regular walking and other forms of physical activity can support cardiovascular health and help improve some lipid abnormalities. People with known cardiovascular disease, chest pain, severe breathlessness, or other exercise limitations should discuss an appropriate activity level with their healthcare professional.
Some Thai hospitals provide comprehensive lipid testing and cardiovascular risk assessment, with additional tests such as Lp(a), apoB, or coronary artery calcium scoring available where indicated. Patients may also have access to modern lipid-lowering medicines and specialist care for complex or inherited lipid disorders.
Many major Thai hospitals have international-patient departments that may assist with medical records, specialist consultations, treatment coordination, visa documentation, travel arrangements, accommodation, interpretation, and follow-up care. Services vary between hospitals.
Consider a cardiologist, endocrinologist, lipid specialist, or internal medicine physician experienced in managing your specific lipid abnormality and cardiovascular risk profile. For complex or inherited dyslipidemia, consider a centre with access to advanced lipid testing, cardiovascular risk assessment, genetic evaluation when appropriate, and long-term specialist follow-up.
There is no single success rate for dyslipidemia treatment because outcomes depend on the type of lipid abnormality, baseline levels, cardiovascular risk, underlying causes, treatment used, and individual response. Appropriate lifestyle changes and lipid-lowering medicines can substantially reduce LDL-C and other atherogenic lipid levels in suitable patients. The main treatment goal is long-term reduction of cardiovascular risk rather than a single measure of treatment success.
Many tertiary Thai hospitals have cardiologists, endocrinologists, diabetologists, internal medicine physicians, and other specialists experienced in managing dyslipidemia and its associated cardiovascular and metabolic conditions. Patients with familial or complex lipid disorders may benefit from multidisciplinary specialist care.
The risks depend on the treatment used. Statins and other lipid-lowering medicines may cause medication-specific adverse effects, although many patients tolerate them well. Depending on the medicine, monitoring may include assessment of muscle symptoms, liver enzymes, kidney function, or other relevant parameters.
Consult a healthcare professional to review your lipid results, assess your overall cardiovascular risk, and identify possible contributing conditions, such as diabetes or hypothyroidism. Depending on your results and medical history, treatment may include lifestyle changes, lipid-lowering medication, or further testing. If you have very high triglycerides and develop severe abdominal pain, particularly with nausea or vomiting, seek urgent medical attention because acute pancreatitis is possible.
Dyslipidemia does not usually cause physical deformities. However, some inherited lipid disorders can cause cholesterol deposits in tendons, under the skin, or as yellowish deposits around the eyelids. The more significant long-term concern is atherosclerosis, which can increase the risk of heart attack, stroke, and peripheral artery disease.
Yes, particularly when dyslipidemia is associated with cardiovascular disease, diabetes, obesity, or other chronic conditions. Dyslipidemia itself is often asymptomatic, but long-term cardiovascular complications can affect physical activity, independence, work, and daily functioning. Effective lipid management can help reduce the risk of these complications.
Yes. Persistently elevated atherogenic lipoproteins can contribute to plaque formation and increase the risk of coronary artery disease, heart attack, stroke, and peripheral artery disease. Severe hypertriglyceridemia can also increase the risk of acute pancreatitis. Risk depends on the lipid abnormality, its duration, and the presence of other cardiovascular risk factors.
The risk of developing or worsening dyslipidemia can often be reduced through a heart-healthy diet, regular physical activity, maintaining a healthy weight where appropriate, avoiding tobacco, limiting excessive alcohol intake, and managing conditions such as diabetes and hypothyroidism. Regular lipid screening is important, particularly for people with a family history of inherited lipid disorders or premature cardiovascular disease.
Dyslipidemia can affect people of all ages, but risk is higher in people with a family history of lipid disorders or premature cardiovascular disease, obesity, physical inactivity, diabetes, hypothyroidism, chronic kidney disease, certain liver conditions, or specific medication exposures. Some inherited disorders, such as familial hypercholesterolemia, can cause very high LDL-C levels from a young age.
Reviewer
Dr. Ashish George
Gastroenterologist
18 Years of Experience
Dr. Ashish George is one of the leading names in HPB surgery & liver transplantation and has about 18+ years of experience.He is a principal consultant & unit head of liver transplant at Fortis Shalimar Bagh. View More
Last Reviewed - January 2026